MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Not suitable for compliance aid: packaged with a desiccant.

Provenance

Compatibility recommendation derived from Concerta XL 36mg tablets (Janssen-Cilag Ltd).

Stability Notes

Not suitable for compliance aid: packaged with a desiccant.

Provenance

Compatibility recommendation derived from Concerta XL 36mg tablets (Janssen-Cilag Ltd).

Stability Notes

Not suitable for compliance aid: packaged with a desiccant.

Provenance

Compatibility recommendation derived from Concerta XL 54mg tablets (Janssen-Cilag Ltd).

Stability Notes

Not suitable for compliance aid: packaged with a desiccant.

Provenance

Compatibility recommendation derived from Concerta XL 54mg tablets (Janssen-Cilag Ltd).

Stability Notes

Not suitable for compliance aid: packaged with a desiccant.

Provenance

Compatibility recommendation derived from Concerta XL 54mg tablets (Janssen-Cilag Ltd).

Stability Notes

There are no stability notes available for this medicine.

Provenance

This compatibility recommendation is derived from Sertraline 100mg tablets (Accord Healthcare Ltd).

Stability Notes

There are no stability notes available for this medicine.

Provenance

This compatibility recommendation is derived from Sertraline 50mg tablets (Accord Healthcare Ltd).

Stability Notes

Store in an airtight container. Protect from light and moisture.

Legislation states unless there are exceptional circumstances, valproate-containing medicines must always be dispensed in the manufacturer’s original full pack. The Patient Information Leaflet should be provided.

Provenance

This compatibility recommendation is derived from Convulex 150mg gastro-resistant capsules (Gerot Lannach UK Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.